Vol 25, No 1 (2021)
Case report
Published online: 2021-03-22

open access

Page views 548
Article views/downloads 575
Get Citation

Connect on Social Media

Connect on Social Media

Primary aldosteronism and coronary-pulmonary artery fistula: coincidence or causal link? A case report and literature review

Luigi Marzano1
Arterial Hypertension 2021;25(1):47-52.


Background: Primary aldosteronism (PA) is the most frequent form of potentially reversible hypertension and
coronary-pulmonary fistulas are increasingly recognized during routine coronary angiography or multidetector computed
tomography for analysis of chest pain in hypertensive patients. Aldosterone hypersecretion has been associated
with endothelial proliferation and pathological remodeling of the heart and arteries, though coronary artery fistulas
have never been reported in patients with PA.

Case presentation: The authors report the first case of PA with dilated cardiomyopathy unusually associated with
electrocardiographic changes after normalization of hypokalemia and with the finding of a coronary-pulmonary
fistula during coronary angiography. The clinical presentation and our diagnosis and treatment decision-making in
the COVID-19 era are discussed below.

Conclusions: Our case suggests a potential link between hypertensive patients with coronary artery fistulas and PA.

Article available in PDF format

View PDF Download PDF file


  1. Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(5): 1889–1916.
  2. Commins J. Surgeon general urges providers to consider stopping all elective surgeries — hospitals push back. Health Leaders Health Leaders Media, Brentwood, TN 2020.
  3. Marzano L, Colussi G, Sechi LA, et al. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies. Am J Hypertens. 2015; 28(3): 312–318.
  4. Catena C, Colussi G, Di Fabio A, et al. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism. Horm Metab Res. 2010; 42(6): 440–445.
  5. Monticone S, D'Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018; 6(1): 41–50.
  6. Tsai CH, Pan CT, Chang YY, et al. TAIPAI Study Group. Endothelial Dysfunction in Primary Aldosteronism. Int J Mol Sci. 2019; 20(20): 131–147.
  7. Gravez B, Tarjus A, Pelloux V, et al. Aldosterone promotes cardiac endothelial cell proliferation in vivo. J Am Heart Assoc. 2015; 4(1): e001266.
  8. Hung CS, Sung SH, Liao CW, et al. TAIPAI Study Group. Aldosterone Induces Vascular Damage. Hypertension. 2019; 74(3): 623–629.
  9. Sztechman D, Czarzasta K, Cudnoch-Jedrzejewska A, et al. Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries. J Physiol Pharmacol. 2018; 69(6).
  10. Catena C, Colussi GL, Marzano L, et al. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism. Horm Metab Res. 2012; 44(3): 188–193.
  11. Davis JO, Urquhart J, Higgins JT, et al. Hypersecretion of Aldosterone in Dogs with a Chronic Aortic-Caval Fistula and High Output Heart Failure. Circ Res. 1964; 14: 471–485.
  12. Inoue K, Goldwater D, Allison M, et al. Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium: The Multi-Ethnic Study of Atherosclerosis. Hypertension. 2020; 76(1): 113–120.
  13. Widimsky J, Strauch B, Petrák O, et al. Vascular disturbances in primary aldosteronism: clinical evidence. Kidney Blood Press Res. 2012; 35(6): 529–533.
  14. Wilkinson-Berka JL, Suphapimol V, Jerome JR, et al. Angiotensin II and aldosterone in retinal vasculopathy and inflammation. Exp Eye Res. 2019; 187: 107766.
  15. Liu J, Wada Y, Katsura M, et al. Rho-Associated Coiled-Coil Kinase (ROCK) in Molecular Regulation of Angiogenesis. Theranostics. 2018; 8(21): 6053–6069.
  16. Kishimoto S, Oki K, Maruhashi T, et al. Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study. J Hypertens. 2019; 37(5): 1083–1095.
  17. Zhang J, Yang J, Li Y. Dilated cardiomyopathy and aldosteronoma: a causal link? ESC Heart Fail. 2020; 7(1): 334–336.
  18. Said SAM, Nijhuis RLG, Akker JW, et al. Unilateral and multilateral congenital coronary-pulmonary fistulas in adults: clinical presentation, diagnostic modalities, and management with a brief review of the literature. Clin Cardiol. 2014; 37(9): 536–545.
  19. Huang Z, Liu Z, Ye S. The role of the fractional flow reserve in the coronary steal phenomenon evaluation caused by the coronary-pulmonary fistulas: case report and review of the literature. J Cardiothorac Surg. 2020; 15(1): 32.
  20. Musa N, Tandean P, Mappangara I, et al. Electrocardiogram pattern pre and post potassium correction in hypokalemia. International Journal of Medical Reviews and Case Reports. 2019(0): 1.